Search Results - Christian Behrenbruch
- Showing 1 - 2 results of 2
-
1
-
2
[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial by Brian Shuch, Allan J. Pantuck, Jean‐Christophe Bernhard, Michael A. Morris, Viraj Master, Andrew M. Scott, Charles van Praet, Clément Bailly, Bülent Önal, Tamer Aksoy, Robin Merkx, David M Schuster, Sze Ting Lee, Neeta Pandit‐Taskar, Alice C. Fan, Phillip Allman, Karl P. Schmidt, Libuse Tauchmanovà, Michael P. Wheatcroft, Christian Behrenbruch, Colin Hayward, Peter Mulders
Published 2024Artigo